Carol Bramson
Angel investor in Clinton
Clinton, Connecticut
Carol Bramson, Angel investor in Clinton is an active investor based in Clinton, Connecticut. This profile covers what Carol Bramson backs, at which stage, and how founders can reach out in 2026.
Ms. Carol Bramson is a Co-Founder and serves as Chief Executive Officer & Partner at Side by Side Pet. Ms. Bramson is an Angel Investor. She served as a Senior Advisor at WellVest Capital. She served as an Operating Partner at Huron Capital. She became a Huron Operating Partner in 2003. Ms. Bramson served as the Chief Executive Officer, Director, and President at Summer Infant. Prior to joining Summer Infant, Ms. Bramson was Managing Director of 212 Equity Management, a private investment firm that she founded in 2010 focused on the healthy living sector. She has more than 20 years of experience building strong businesses in a variety of industries. Her private equity experience began in 1988 with Essex Venture Partners (now Essex Woodlands Health Ventures), a healthcare venture capital firm founded in Chicago and joined Banc One Equity Capital (formerly First Chicago Equity Capital) in 1992, where she became a Partner with responsibility for all phases of the investment process. In 2001, Bramson founded TBG Capital, which provided equity capital and advisory services to companies to facilitate start-ups, growth, and/or acquisitions. In addition to direct equity investments, Bramson has provided ongoing industry, financial, and strategic advisory services to several organizations in the consumer products, wealth management, and specialty chemicals sectors. In addition to serving on the Summer Infant board since 2012, Bramson is currently a board member of the private company, White Cloud Nutrition LLC. She holds a B.S. in Finance (with honors) from DePaul University and an MBA from The University of Chicago.
- Investor type
- Angel
- Stages
- Pre SeedSeed
- Invests in
- Healthcare & BiotechConsumer & RetailE-commerce & D2CManufacturing & Industrial
- Location
- Clinton, Connecticut
- Typical check
- $150K
- Past investments
- 4
Notable investments
How to reach Carol Bramson
Angels and operators like Carol Bramson reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.
Reach active investors like this one
About this profile
This profile is part of Round Funded, an investor database and outreach platform for founders. It covers 60,000+ active VCs, angels, family offices and accelerators with verified contacts, lets you send pitches from your own Gmail, and includes a free Data Room for your raise. How this data is built.
Cite this page
Round Funded. "Carol Bramson." Round Funded investor database, updated September 8, 2026.
Stable URL, it will not change: https://www.roundfunded.com/en/investor/carol-bramson
Frequently Asked Questions
What does Carol Bramson invest in?
Carol Bramson invests in Healthcare & Biotech, Consumer & Retail, E-commerce & D2C and Manufacturing & Industrial, typically at Pre Seed and Seed. Match your sector and stage, then reach out with a personalized pitch.
What stage does Carol Bramson invest at?
Carol Bramson typically invests at Pre Seed and Seed. Lead with traction that fits the stage when you reach out.
What is Carol Bramson's typical check size?
Carol Bramson typically writes checks around $150K. Use it as a signal for whether your raise fits their stage.
How do founders reach investors like this?
Round Funded lists active investors with verified, professional contact details for signed-up founders. Filter by sector, stage and location, then send a personalized pitch from your own inbox.
What is Round Funded?
Round Funded is an investor database and outreach platform for startup founders. It lists 60,000+ active investors with verified contacts, filtered to recent investment activity, and lets founders send personalized pitches from their own Gmail, track replies, and share a free Data Room. Round+ starts at $99 per month with a 3-day trial.